The future of metabolomics and lipidomics profiling

Nicola Zamboni handpicks technologies for the PHRT Clinical Metabolomics Analysis Center with the potential to enhance clinical insights and decision-making, accelerating the voyage toward personalized medicine.

Streamlining metabolomic and lipidomic analyses to enable personalized therapies

The sheer amount of data gained via MS metabolomics and lipidomics analyses greatly contributes to our knowledge of biological systems, disease mechanisms, and possible therapeutic targets.

Applying novel technologies to these efforts enables researchers and clinicians to work more effectively and obtain insights faster. Sophisticated instrumentation empowers abilities and provides higher sensitivity, durability, and speed, enabling more precise and detailed analyses of complicated biological samples.

With these tools, scientists can distinguish and quantify a wider spectrum of metabolites and lipids, resulting in a better understanding of biochemical pathways and disease processes.

Faster, deeper, simpler: a new era in metabolomics and lipidomics profiling

Dr. Nicola Zamboni investigates the abilities of the ZenoTOF 7600 system in his labs. As an extremely flexible system, it has all the properties Dr. Zamboni’s team needs: speed, sensitivity, precision, dynamic range, a high quantity of MS2 information, and comprehensive structural elucidation, all in a singular, complete package.

This sophisticated technology meets their expectations and empowers them to conduct their day-to-day tasks with both confidence and ease.

Dr. Zamboni showcases the system’s superb performance by applying it to lipidomics analyses—large-scale studies frequently requiring speed. With no start-up time, the system demonstrates flexibility and accuracy, presenting its ability to grasp complicated lipidomic samples without alteration.

Using EAD fragmentation, vast quantities of data can be acquired quickly, enabling more profound insights throughout a routine analysis. This timesaving method delivers rich information that aids in uncovering complicated biological processes.

The ZenoTOF 7600 system is entertaining and valuable for Nicola Zamboni and his team. It exceeds expectations and enables them to rapidly obtain useful data.

Key takeaways 

  • The ZenoTOF 7600 system merges top speed, robustness, sensitivity, dynamic range, and deep collection of rich MS2 data on a chromatographic timescale
  • EAD spectra have large quantities of data. Lipid EAD spectra are predictable with naïve fragments
  • We can effectively identify, calculate, and structurally explain over 1000 lipids in 2-min gradients in real samples

The future of metabolomics and lipidomics profiling

Image Credit: SCIEX

Click here to learn more

About SCIEX

SCIEX mission is to deliver solutions for the precision detection and quantitation of molecules, empowering their customers to protect and advance the wellness and safety of all.

SCIEX has led the field of mass spectrometry for 50 years. From the moment we launched the first ever commercially successful triple quad in 1981, they have developed groundbreaking technologies and solutions that influence life-changing research and outcomes.

Today, as part of the Danaher family of global life science and technology innovators, they continue to pioneer robust solutions in mass spectrometry and capillary electrophoresis. But they don’t just develop products. It is what they do together with their customers that sets them apart. That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust to better inform critical decisions. Decisions that positively impact lives.

They proudly stand behind our tagline: The Power of Precision. 


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Oct 18, 2024 at 6:37 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    SCIEX. (2024, October 18). The future of metabolomics and lipidomics profiling. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/whitepaper/20241018/The-future-of-metabolomics-and-lipidomics-profiling.aspx.

  • MLA

    SCIEX. "The future of metabolomics and lipidomics profiling". News-Medical. 21 November 2024. <https://www.news-medical.net/whitepaper/20241018/The-future-of-metabolomics-and-lipidomics-profiling.aspx>.

  • Chicago

    SCIEX. "The future of metabolomics and lipidomics profiling". News-Medical. https://www.news-medical.net/whitepaper/20241018/The-future-of-metabolomics-and-lipidomics-profiling.aspx. (accessed November 21, 2024).

  • Harvard

    SCIEX. 2024. The future of metabolomics and lipidomics profiling. News-Medical, viewed 21 November 2024, https://www.news-medical.net/whitepaper/20241018/The-future-of-metabolomics-and-lipidomics-profiling.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.